IMNM
Price
$8.86
Change
+$0.07 (+0.80%)
Updated
May 1 closing price
Capitalization
770.92M
6 days until earnings call
RXRX
Price
$5.50
Change
-$0.09 (-1.61%)
Updated
May 1 closing price
Capitalization
2.24B
3 days until earnings call
Ad is loading...

IMNM vs RXRX

Header iconIMNM vs RXRX Comparison
Open Charts IMNM vs RXRXBanner chart's image
Immunome
Price$8.86
Change+$0.07 (+0.80%)
Volume$717.28K
Capitalization770.92M
Recursion Pharmaceuticals
Price$5.50
Change-$0.09 (-1.61%)
Volume$12.94M
Capitalization2.24B
IMNM vs RXRX Comparison Chart
Loading...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMNM vs. RXRX commentary
May 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMNM is a Buy and RXRX is a Hold.

Ad is loading...
COMPARISON
Comparison
May 02, 2025
Stock price -- (IMNM: $8.86 vs. RXRX: $5.50)
Brand notoriety: IMNM and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMNM: 61% vs. RXRX: 62%
Market capitalization -- IMNM: $770.92M vs. RXRX: $2.24B
IMNM [@Biotechnology] is valued at $770.92M. RXRX’s [@Biotechnology] market capitalization is $2.24B. The market cap for tickers in the [@Biotechnology] industry ranges from $293.01B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMNM’s FA Score shows that 0 FA rating(s) are green whileRXRX’s FA Score has 0 green FA rating(s).

  • IMNM’s FA Score: 0 green, 5 red.
  • RXRX’s FA Score: 0 green, 5 red.
According to our system of comparison, RXRX is a better buy in the long-term than IMNM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMNM’s TA Score shows that 5 TA indicator(s) are bullish while RXRX’s TA Score has 4 bullish TA indicator(s).

  • IMNM’s TA Score: 5 bullish, 4 bearish.
  • RXRX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, IMNM is a better buy in the short-term than RXRX.

Price Growth

IMNM (@Biotechnology) experienced а +3.99% price change this week, while RXRX (@Biotechnology) price change was -4.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.35%. For the same industry, the average monthly price growth was +8.65%, and the average quarterly price growth was -6.40%.

Reported Earning Dates

IMNM is expected to report earnings on Aug 13, 2025.

RXRX is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+3.35% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($2.24B) has a higher market cap than IMNM($771M). IMNM YTD gains are higher at: -16.573 vs. RXRX (-18.639). IMNM has higher annual earnings (EBITDA): -109.95M vs. RXRX (-426.72M). RXRX has more cash in the bank: 594M vs. IMNM (240M). IMNM has less debt than RXRX: IMNM (2.72M) vs RXRX (108M). RXRX has higher revenues than IMNM: RXRX (58.5M) vs IMNM (10.1M).
IMNMRXRXIMNM / RXRX
Capitalization771M2.24B34%
EBITDA-109.95M-426.72M26%
Gain YTD-16.573-18.63989%
P/E RatioN/AN/A-
Revenue10.1M58.5M17%
Total Cash240M594M40%
Total Debt2.72M108M3%
TECHNICAL ANALYSIS
Technical Analysis
IMNMRXRX
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
75%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 1 day ago
81%
N/A
Declines
ODDS (%)
Bearish Trend 25 days ago
87%
Bearish Trend 1 day ago
89%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
70%
Aroon
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FPACX40.15N/A
N/A
FPA Crescent
CDOYX38.28N/A
N/A
Columbia Dividend Opportunity Inst3
FRIEX16.09N/A
N/A
Federated Hermes Emerging Markets Eq R6
FSDPX84.72N/A
N/A
Fidelity Select Materials
WISGX18.97N/A
N/A
Segall Bryant & Hamill Small Cap GrInstl

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with IDYA. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
+0.80%
IDYA - IMNM
56%
Loosely correlated
+1.69%
KYMR - IMNM
55%
Loosely correlated
+0.82%
RXRX - IMNM
53%
Loosely correlated
-1.61%
BEAM - IMNM
53%
Loosely correlated
-0.50%
CCCC - IMNM
51%
Loosely correlated
-0.61%
More

RXRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RXRX has been closely correlated with CRSP. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if RXRX jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXRX
1D Price
Change %
RXRX100%
-1.61%
CRSP - RXRX
72%
Closely correlated
-2.43%
BEAM - RXRX
63%
Loosely correlated
-0.50%
NTLA - RXRX
60%
Loosely correlated
-2.59%
ABSI - RXRX
59%
Loosely correlated
-1.30%
PRME - RXRX
58%
Loosely correlated
+0.58%
More